期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Study on biocompatibility of PDLLA/HA/DBM with co-cultured human osteoblasts in vitro
1
作者 郭乔楠 赵建华 卢佳友 《Journal of Medical Colleges of PLA(China)》 CAS 2003年第5期277-282,共6页
Objective: To evaluate the osteocompatibility of D, L-polylactic/hydroxyapatite/decalcifying bone matrix (PDLLA/HA/DBM), and compare with PDLLA and DBM. Methods: Human primary osteoblasts isolated from the femoral hea... Objective: To evaluate the osteocompatibility of D, L-polylactic/hydroxyapatite/decalcifying bone matrix (PDLLA/HA/DBM), and compare with PDLLA and DBM. Methods: Human primary osteoblasts isolated from the femoral head of patients were inoculated onto PDLLA/HA/DBM, PLA and DBM respectively. The proliferation rate and collagen Ⅰ expression were detected. The interface between biomaterial and osteoblasts was investigated with phase contrast microscopy and electron scanning microscopy. Results: Best proliferation rate was observed with the PDLLA/HA/DBM and followed by DBM and PLA, suggesting that PDLLA/HA/DBM satisfying most requirements for the cultivation of human osteoblasts. Scanning electron microscopy showed the morphology of osteoblasts was correlated with the proliferation data. The cells, well spread and flattened, were attached closely on the surface of biomaterial with an arched structure and had normal morphology. The extracellular collagenous matrixs covered the surface of biomaterial and packed the granules of biomaterial. Conclusion: PDLLA/HA/DBM can form osteointerface early and have a good biocompability. 展开更多
关键词 biomaterial OSTEOBLASTS BIOCOMPATIBILITY cell culture D l-polylactic/hydroxyapatite/decalcifying bone matrix(PDLLA/HA/DBM)
暂未订购
人工骨支撑棒结合脱钙骨基质治疗股骨头缺血性坏死的临床观察 被引量:8
2
作者 王金龙 杨述华 +2 位作者 叶树楠 王晶 刘先哲 《中华显微外科杂志》 CSCD 北大核心 2015年第3期226-230,共5页
目的 回顾性分析髓芯减压联合纳米晶胶原基人工骨支撑棒结合脱钙骨基质治疗早期股骨头坏死临床疗效及其影响因素. 方法 2012年8月至2013年5月,华中科技大学附属协和医院骨科收治早期股骨头坏死的患者46例(50髋),年龄23 - 51岁,平均34.... 目的 回顾性分析髓芯减压联合纳米晶胶原基人工骨支撑棒结合脱钙骨基质治疗早期股骨头坏死临床疗效及其影响因素. 方法 2012年8月至2013年5月,华中科技大学附属协和医院骨科收治早期股骨头坏死的患者46例(50髋),年龄23 - 51岁,平均34.2岁;所有患者经大腿外侧小切口入路,行髓芯减压联合纳米晶胶原基人工骨支撑棒结合脱钙骨基质植入术.术后预防性地静脉给予抗生素及抗凝治疗;术后3周内禁止负重,3周后可部分负重,逐渐增加至完全负重.所有患者均获随访,进行临床及影像学评估.临床评估采用Harris评分系统,评价术后患髋功能改善情况;影像学评估主要是于术后1、3、6、12、18个月摄取骨盆X线片,观察股骨头修复及有无坏死情况. 结果 术后12个月进行疗效评估,术前Harris评分平均为(65.6±10.6)分,术后提高至(87.5±15.3)分,提高分数平均为(21.8±13.2)分(P<0.05).参考Harris评分系统,本组50髋病例中,优30髋,良14髋,可2髋,差4髋,优良率达88%.Kaplan-Meier生存曲线分析表明,术后12个月成功率为92%,X线片的结果显示有4髋表现出影像学进展,影像学变化与临床症状、体征改变相符合. 结论 髓芯减压联合纳米晶胶原基人工骨支撑棒结合脱钙骨基质植入术治疗早期股骨头坏死,治疗效果优良,适合于Ⅰ期和Ⅱ期的股骨头坏死患者. 展开更多
关键词 股骨头缺血性坏死 纳米晶胶原基 人工骨支撑棒 脱钙骨基质
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部